866-997-4948(US-Canada Toll Free)

Global and Europe Drugs of Nervous System Market - Analysis and Outlook to 2022

Published By :

EU Research

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 130 Pages

This report presents a comprehensive overview of the Drugs of Nervous System market in Europe. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.
This report provides a detailed analysis of the market, its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Drugs of Nervous System industry.
This report focus Global and Europe market, it covers details players regions product type and other details as following:

Key Players
Zhejiang Chiral Medicine Chemicals
Gedeon Richter Plc.Hungary
S.P. QUIMICA, S.A. ES 43330 Riudoms
Janssen Pharmaceutica N.V. Belgium
Moehs Iberica S.L. ES 08191 Rubi
Sanofi Aventis Deutschland France
TEVA CZECH INDUSTRIES Opava-Komarov
Taiwan Biotech Co.Ltd
PATHEON AUSTRIA GMBH & CO. KG AT Linz
GlaxoSmithKline Pharmaceuticals S.A.Poland
ALKALOIDA CHEMICAL Tiszavasvari
Actavis hf. Iceland
Siegfried Ltd CH 4800 Zofingen
UCB Pharma S.A.Belgium
KATWIJK CHEMIE BV NL BA Katwijk ZH
Janssen-Cilag AG Puerto Rico
F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore
Bayer Vital GmbH Germany
Ergypharm FR 67452 Mundolsheim
Roquette Freres France
HARMAN FINOCHEM LIMITED IN Mumbai
Pfizer Pharmaceuticals Inc.
MSD PHARMA (SINGAPORE) PTE. LTD.Italy
Sawai Pharmaceutical Co.,Ltd.
Orion Corporation Finland
Nichi-iko Pharmaceutical Co.,Ltd
Gedeon Richter Plc. Hungary
Novartis Farma S.P.A. Italy

Key Regions
Europe
----Germany
----United Kingdom
----France
----Italy
----Spain
----Russia
----Netherland
----Poland
----Others
United States
China
Japan
India
Others

Key Product Type
by Product Antiparkinsonism drugs
L-Dopa,
Carbidopa,
Benserazide,
Sinemet,
Selegiline

by Product Antimyasthenics
Neostigmine,
Neostigmine Methylsulfate,
Pyridostigmine Bromide,
Galanthamine,
Edrophonium Chloride

by Product Antiepileptics
Phenytoin Sodium,
Carbamazepine,
Phenobarbital,
Primidone,
Ethosuximide

by Product Cerebrovascular disease drugs
Nimodipine,
Carfergot,
Mannitol,
Acetazolamide,
Piracetam

by Product Sedative-hypnotic drugs
Diazepam,
Chlordiazepoxide,
Oxazepam,
Nitrazepam,
Flunitrazepam

Key Applications
Pharmacy
Hospital
Department of psychiatry
Department of Encephalopathy
Department of neurology

Table of Contents

1 Market Outline
1.1 Research Methodology
1.1.1 Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
1.1.2 Data Source
Secondary Sources
Primary Sources
1.1.3 Disclaimer
1.2Regulatory Factors
1.3 End-User Analysis
1.4 Strategic Benchmarking
1.5 Industry Chain and Supply Chain
1.5.1 Drugs of Nervous System Industry Chain Structure
1.5.1.1 R&D
1.5.1.2 Raw Materials (Components)
1.5.1.3 Manufacturing Plants
1.5.1.4 Regional Trading (Import Export and Local Sales)
1.5.1.5 Online Sales Channel
1.5.1.6 Offline Channel
1.5.1.7 End Users
1.5.2 Drugs of Nervous System Manufacturing
1.5.2.1 Key Components
1.5.2.2 Assembly Manufacturing
1.5.3 Consumer Preference
1.5.4 Behavioral Habits
1.5.5 Marketing Environment
1.6 SWOT Analysis
1.7 Feasibility Analysis
1.8 Development Trend and Research Conclusion
1.8.1 Development Trend
1.8.2 Research Conclusion
2 Drugs of Nervous System Product Overview
2.1 Global and Europe Drugs of Nervous System Market Sales Volume Revenue and Price 2012-2022
2.2 Drugs of Nervous System, by Product Antiparkinsonism drugs2012-2022
2.2.1 Global and Europe Drugs of Nervous System Sales Market Share by Product Antiparkinsonism drugs2012-2022
2.2.2 Global and Europe Drugs of Nervous System Revenue Market Share by Product Antiparkinsonism drugs2012-2022
2.2.3 Global and Europe Drugs of Nervous System Price by Product Antiparkinsonism drugs2012-2022
2.2.4 L-Dopa
2.2.5 Carbidopa
2.2.6 Benserazide
2.2.7 Sinemet
2.2.8 Selegiline
2.2.9 Amantadine
2.2.10 Bromocriptine
2.2.11 Pergolide
2.2.12 Artane
2.3 Drugs of Nervous System, by Product Antimyasthenics 2012-2022
2.3.1 Global and Europe Drugs of Nervous System Sales Market Share by Product Antimyasthenics 2012-2022
2.3.2 Global and Europe Drugs of Nervous System Revenue Market Share by Product Antimyasthenics 2012-2022
2.3.3 Global and Europe Drugs of Nervous System Price by Product Antimyasthenics 2012-2022
2.3.4 Neostigmine
2.3.5 Neostigmine Methylsulfate
2.3.6 Pyridostigmine Bromide
2.3.7 Galanthamine
2.3.8 Edrophonium Chloride
2.4 Drugs of Nervous System, by Product Antiepileptics 2012-2022
2.4.1 Global and Europe Drugs of Nervous System Sales Market Share by Product Antiepileptics 2012-2022
2.4.2 Global and Europe Drugs of Nervous System Revenue Market Share by Product Antiepileptics 2012-2022
2.4.3 Global and Europe Drugs of Nervous System Price by Product Antiepileptics 2012-2022
2.4.4 Phenytoin Sodium
2.4.5 Carbamazepine
2.4.6 Phenobarbital
2.4.7 Primidone
2.4.8 Ethosuximide
2.4.9 Sodium valproate
2.4.10 Clonazepam
2.4.11 Trimethadione
2.4.12 Lamotrigine
2.4.13 Sultiame
2.4.14 Felbamate
2.4.15 Levetiracetam
2.4.16 Topamax
2.5 Drugs of Nervous System, by Product Cerebrovascular disease drugs 2012-2022
2.5.1 Global and Europe Drugs of Nervous System Sales Market Share by Product Cerebrovascular disease drugs 2012-2022
2.5.2 Global and Europe Drugs of Nervous System Revenue Market Share by Product Cerebrovascular disease drugs 2012-2022
2.5.3 Global and Europe Drugs of Nervous System Price by Product Cerebrovascular disease drugs 2012-2022
2.5.4 Nimodipine
2.5.5 Carfergot
2.5.6 Mannitol
2.5.7 Acetazolamide
2.5.8 Piracetam
2.6 Drugs of Nervous System, by Product Sedative-hypnotic drugs 2012-2022
2.6.1 Global and Europe Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs 2012-2022
2.6.2 Global and Europe Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs 2012-2022
2.6.3 Global and Europe Drugs of Nervous System Price by Product Sedative-hypnotic drugs 2012-2022
2.6.4 Diazepam
2.6.5 Chlordiazepoxide
2.6.6 Oxazepam
2.6.7 Nitrazepam
2.6.8 Flunitrazepam
2.6.9 Estazolam
2.6.10 Lorazepam
2.6.11 Meprobamate
2.6.12 Hydroxyzine
2.6.13 Captodiamine
2.6.14 Piperilate
2.6.15 Chlormezanone
2.6.16 Trimetozine
2.6.17 Oryzanol
2.6.18 Benzoctamine
2.6.19 Gastrodine
2.6.20 Glutethimide
2.7 Drugs of Nervous System, by Product Sedative-hypnotic drugs 2012-20221.6 Drugs of Nervous System, by Product Others 2012-2022
2.7.1 Global Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs 2012-2022
2.7.2 Global Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs 2012-2022
2.7.3 Global Drugs of Nervous System Price by Product Sedative-hypnotic drugs 2012-2022
2.7.4 Diazepam
2.7.5 Citicoline
2.7.6 Nikethamide
2.7.7 Lobeline
2.7.8 Piracetam
2.7.9 Ligustrazine
2.7.10 Flunarizine
2.7.11 Cerebroprotein Hydrolysate
2.7.12 Sodium Aescinate
2.7.13 Troxerutin
3 Drugs of Nervous System Top 30 Brands Profile
3.1 Zhejiang Chiral Medicine Chemicals
3.1.1 Zhejiang Chiral Medicine Chemicals Company Details and Competitors
3.1.2 Zhejiang Chiral Medicine Chemicals Key Drugs of Nervous System Models and Performance
3.1.3 Zhejiang Chiral Medicine Chemicals Drugs of Nervous System Business SWOT Analysis and Forecast
3.1.4 Zhejiang Chiral Medicine Chemicals Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.2 S.P. QUIMICA, S.A. ES 43330 Riudoms
3.2.1 S.P. QUIMICA, S.A. ES 43330 Riudoms Company Details and Competitors
3.2.2 S.P. QUIMICA, S.A. ES 43330 Riudoms Key Drugs of Nervous System Models and Performance
3.2.3 S.P. QUIMICA, S.A. ES 43330 Riudoms Drugs of Nervous System Business SWOT Analysis and Forecast
3.2.4 S.P. QUIMICA, S.A. ES 43330 Riudoms Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.3 Moehs Iberica S.L. ES 08191 Rubi
3.3.1 Moehs Iberica S.L. ES 08191 Rubi Company Details and Competitors
3.3.2 Moehs Iberica S.L. ES 08191 Rubi Key Drugs of Nervous System Models and Performance
3.3.3 Moehs Iberica S.L. ES 08191 Rubi Drugs of Nervous System Business SWOT Analysis and Forecast
3.3.4 Moehs Iberica S.L. ES 08191 Rubi Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.4 TEVA CZECH INDUSTRIES Opava-Komarov
3.4.1 TEVA CZECH INDUSTRIES Opava-Komarov Company Details and Competitors
3.4.2 TEVA CZECH INDUSTRIES Opava-Komarov Key Drugs of Nervous System Models and Performance
3.4.3 TEVA CZECH INDUSTRIES Opava-Komarov Drugs of Nervous System Business SWOT Analysis and Forecast
3.4.4 TEVA CZECH INDUSTRIES Opava-Komarov Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.5 PATHEON AUSTRIA GMBH & CO. KG AT Linz
3.5.1 PATHEON AUSTRIA GMBH & CO. KG AT Linz Company Details and Competitors
3.5.2 PATHEON AUSTRIA GMBH & CO. KG AT Linz Key Drugs of Nervous System Models and Performance
3.5.3 PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Business SWOT Analysis and Forecast
3.5.4 PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.6 ALKALOIDA CHEMICAL Tiszavasvari
3.6.1 ALKALOIDA CHEMICAL Tiszavasvari Company Details and Competitors
3.6.2 ALKALOIDA CHEMICAL Tiszavasvari Key Drugs of Nervous System Models and Performance
3.6.3 ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Business SWOT Analysis and Forecast
3.6.4 ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.7 Siegfried Ltd CH 4800 Zofingen
3.7.1 Siegfried Ltd CH 4800 ZofingenCompany Details and Competitors
3.7.2 Siegfried Ltd CH 4800 ZofingenKey Drugs of Nervous System Models and Performance
3.7.3 Siegfried Ltd CH 4800 ZofingenDrugs of Nervous System Business SWOT Analysis and Forecast
3.7.4 Siegfried Ltd CH 4800 ZofingenDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.8 KATWIJK CHEMIE BV NL BA Katwijk ZH
3.8.1 KATWIJK CHEMIE BV NL BA Katwijk ZH Company Details and Competitors
3.8.2 KATWIJK CHEMIE BV NL BA Katwijk ZH Key Drugs of Nervous System Models and Performance
3.8.3 KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Business SWOT Analysis and Forecast
3.8.4 KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.9 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore
3.9.1 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Company Details and Competitors
3.9.2 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Key Drugs of Nervous System Models and Performance
3.9.3 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Business SWOT Analysis and Forecast
3.9.4 F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.10 Ergypharm FR 67452 Mundolsheim
3.10.1 Ergypharm FR 67452 Mundolsheim Company Details and Competitors
3.10.2 Ergypharm FR 67452 Mundolsheim Key Drugs of Nervous System Models and Performance
3.10.3 Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Business SWOT Analysis and Forecast
3.10.4 Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.11 HARMAN FINOCHEM LIMITED IN Mumbai
3.11.1 HARMAN FINOCHEM LIMITED IN MumbaiCompany Details and Competitors
3.11.2 HARMAN FINOCHEM LIMITED IN MumbaiKey Drugs of Nervous System Models and Performance
3.11.3 HARMAN FINOCHEM LIMITED IN MumbaiDrugs of Nervous System Business SWOT Analysis and Forecast
3.11.4 HARMAN FINOCHEM LIMITED IN MumbaiDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.12 MSD PHARMA (SINGAPORE) PTE. LTD.Italy
3.12.1 MSD PHARMA (SINGAPORE) PTE. LTD.ItalyCompany Details and Competitors
3.12.2 MSD PHARMA (SINGAPORE) PTE. LTD.ItalyKey Drugs of Nervous System Models and Performance
3.12.3 MSD PHARMA (SINGAPORE) PTE. LTD.ItalyDrugs of Nervous System Business SWOT Analysis and Forecast
3.12.4 MSD PHARMA (SINGAPORE) PTE. LTD.ItalyDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.13 Orion Corporation Finland
3.13.1 Orion Corporation FinlandCompany Details and Competitors
3.13.2 Orion Corporation FinlandKey Drugs of Nervous System Models and Performance
3.13.3 Orion Corporation FinlandDrugs of Nervous System Business SWOT Analysis and Forecast
3.13.4 Orion Corporation FinlandDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.14 Gedeon Richter Plc. Hungary
3.14.1 Gedeon Richter Plc. HungaryCompany Details and Competitors
3.14.2 Gedeon Richter Plc. HungaryKey Drugs of Nervous System Models and Performance
3.14.3 Gedeon Richter Plc. HungaryDrugs of Nervous System Business SWOT Analysis and Forecast
3.14.4 Gedeon Richter Plc. HungaryDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.15 Novartis Farma S.P.A. Italy
3.15.1 Novartis Farma S.P.A. ItalyCompany Details and Competitors
3.15.2 Novartis Farma S.P.A. ItalyKey Drugs of Nervous System Models and Performance
3.15.3 Novartis Farma S.P.A. ItalyDrugs of Nervous System Business SWOT Analysis and Forecast
3.15.4 Novartis Farma S.P.A. ItalyDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.16 Gedeon Richter Plc.Hungary
3.16.1 Gedeon Richter Plc.HungaryCompany Details and Competitors
3.16.2 Gedeon Richter Plc.HungaryKey Drugs of Nervous System Models and Performance
3.16.3 Gedeon Richter Plc.HungaryDrugs of Nervous System Business SWOT Analysis and Forecast
3.16.4 Gedeon Richter Plc.HungaryDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.17 Janssen Pharmaceutica N.V. Belgium
3.17.1 Janssen Pharmaceutica N.V. BelgiumCompany Details and Competitors
3.17.2 Janssen Pharmaceutica N.V. BelgiumKey Drugs of Nervous System Models and Performance
3.17.3 Janssen Pharmaceutica N.V. BelgiumDrugs of Nervous System Business SWOT Analysis and Forecast
3.17.4 Janssen Pharmaceutica N.V. BelgiumDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.18 Sanofi Aventis Deutschland France
3.18.1 Sanofi Aventis Deutschland FranceCompany Details and Competitors
3.18.2 Sanofi Aventis Deutschland FranceKey Drugs of Nervous System Models and Performance
3.18.3 Sanofi Aventis Deutschland FranceDrugs of Nervous System Business SWOT Analysis and Forecast
3.18.4 Sanofi Aventis Deutschland FranceDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.19 Taiwan Biotech Co.Ltd
3.19.1 Taiwan Biotech Co.Ltd Company Details and Competitors
3.19.2 Taiwan Biotech Co.Ltd Key Drugs of Nervous System Models and Performance
3.19.3 Taiwan Biotech Co.Ltd Drugs of Nervous System Business SWOT Analysis and Forecast
3.19.4 Taiwan Biotech Co.Ltd Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.20 GlaxoSmithKline Pharmaceuticals S.A.Poland
3.20.1 GlaxoSmithKline Pharmaceuticals S.A.PolandCompany Details and Competitors
3.20.2 GlaxoSmithKline Pharmaceuticals S.A.PolandKey Drugs of Nervous System Models and Performance
3.20.3 GlaxoSmithKline Pharmaceuticals S.A.PolandDrugs of Nervous System Business SWOT Analysis and Forecast
3.20.4 GlaxoSmithKline Pharmaceuticals S.A.PolandDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.21 Actavis hf. Iceland
3.21.1 Actavis hf. IcelandCompany Details and Competitors
3.21.2 Actavis hf. IcelandKey Drugs of Nervous System Models and Performance
3.21.3 Actavis hf. IcelandDrugs of Nervous System Business SWOT Analysis and Forecast
3.21.4 Actavis hf. IcelandDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.22 UCB Pharma S.A.Belgium
3.22.1 UCB Pharma S.A.BelgiumCompany Details and Competitors
3.22.2 UCB Pharma S.A.BelgiumKey Drugs of Nervous System Models and Performance
3.22.3 UCB Pharma S.A.BelgiumDrugs of Nervous System Business SWOT Analysis and Forecast
3.22.4 UCB Pharma S.A.BelgiumDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.23 Janssen-Cilag AG Puerto Rico
3.23.1 Janssen-Cilag AG Puerto RicoCompany Details and Competitors
3.23.2 Janssen-Cilag AG Puerto RicoKey Drugs of Nervous System Models and Performance
3.23.3 Janssen-Cilag AG Puerto RicoDrugs of Nervous System Business SWOT Analysis and Forecast
3.23.4 Janssen-Cilag AG Puerto RicoDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.24 Bayer Vital GmbH Germany
3.24.1 Bayer Vital GmbH GermanyCompany Details and Competitors
3.24.2 Bayer Vital GmbH GermanyKey Drugs of Nervous System Models and Performance
3.24.3 Bayer Vital GmbH GermanyDrugs of Nervous System Business SWOT Analysis and Forecast
3.24.4 Bayer Vital GmbH GermanyDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.25 Roquette Freres France
3.25.1 Roquette Freres FranceCompany Details and Competitors
3.25.2 Roquette Freres FranceKey Drugs of Nervous System Models and Performance
3.25.3 Roquette Freres FranceDrugs of Nervous System Business SWOT Analysis and Forecast
3.25.4 Roquette Freres FranceDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.26 Pfizer Pharmaceuticals Inc.
3.26.1 Pfizer Pharmaceuticals Inc.Company Details and Competitors
3.26.2 Pfizer Pharmaceuticals Inc.Key Drugs of Nervous System Models and Performance
3.26.3 Pfizer Pharmaceuticals Inc.Drugs of Nervous System Business SWOT Analysis and Forecast
3.26.4 Pfizer Pharmaceuticals Inc.Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.27 Sawai Pharmaceutical Co.,Ltd.
3.27.1 Sawai Pharmaceutical Co.,Ltd.Company Details and Competitors
3.27.2 Sawai Pharmaceutical Co.,Ltd.Key Drugs of Nervous System Models and Performance
3.27.3 Sawai Pharmaceutical Co.,Ltd.Drugs of Nervous System Business SWOT Analysis and Forecast
3.27.4 Sawai Pharmaceutical Co.,Ltd.Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
3.28 Nichi-iko Pharmaceutical Co.,Ltd
3.28.1 Nichi-iko Pharmaceutical Co.,LtdCompany Details and Competitors
3.28.2 Nichi-iko Pharmaceutical Co.,LtdKey Drugs of Nervous System Models and Performance
3.28.3 Nichi-iko Pharmaceutical Co.,LtdDrugs of Nervous System Business SWOT Analysis and Forecast
3.28.4 Nichi-iko Pharmaceutical Co.,LtdDrugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
4 Drugs of Nervous System by Regions 2012-2022
4.1 Global and Europe Drugs of Nervous System Sales Market Share by Regions 2012-2022
4.2 Global and Europe Drugs of Nervous System Revenue Market Share by Regions 2012-2022
4.3 Global and Europe Drugs of Nervous System Price by Regions 2012-2022
4.4 United States
4.5 Europe
4.5.1 Germany
4.5.2 United Kingdom
4.5.3 France
4.5.4 Italy
4.5.5 Spain
4.5.6 Russia
4.5.7 Netherland
4.5.8 Poland
4.5.9 Others in Europe
4.6 China
4.7 Japan
4.8 India
4.9 Southeast Asia
4.10 Others
5 Drugs of Nervous System by Brands 2012-2022
5.1 Global and Europe Drugs of Nervous System Sales Volume Market Share by Brands 2012-2022
5.2 Global and Europe Drugs of Nervous System Revenue Share by Brands 2012-2022
5.3 Global and Europe Top Brands Drugs of Nervous System Key Product Model and Market Performance
5.4 Global and Europe Top Brands Drugs of Nervous System Key Target Consumers and Market Performance
6 Drugs of Nervous System by Consumer 2012-2022
6.1 Global and Europe Drugs of Nervous System Sales Market Share by Consumer 2012-2022
6.2 Pharmacy
6.3 Hospital
6.4 Department of psychiatry
6.5 Department of Encephalopathy
6.6 Department of neurology
6.7 Consuming Habit and Preference

List of Table

List of Tables and Figures

Table Global and Europe Drugs of Nervous System Sales Volume (MT) Revenue (Million USD) and Price (USD/T) 2012-2022
Figure Global and Europe Drugs of Nervous System Revenue (Million USD) and Growth Rate 2012-2022
Figure Global and Europe Drugs of Nervous System Sales Volume (MT) and Growth Rate 2012-2022
Table Global and Europe Drugs of Nervous System Sales (MT) by Product Antiparkinsonism drugs(2012-2022)
Table Global and Europe Drugs of Nervous System Sales Market Share by Product Antiparkinsonism drugs(2012-2022)
Figure Global and Europe Drugs of Nervous System Sales Market Share by Product Antiparkinsonism drugsin 2016
Table Global and Europe Drugs of Nervous System Revenue (Million USD) by Product Antiparkinsonism drugs(2012-2022)
Table Global and Europe Drugs of Nervous System Revenue Market Share by Product Antiparkinsonism drugs(2012-2022)
Figure Global and Europe Drugs of Nervous System Revenue Market Share by Product Antiparkinsonism drugsin 2016
Table Global and Europe Drugs of Nervous System Price (USD/T) by Product Antiparkinsonism drugs(2012-2022)
Table Top Brands of L-Dopa Drugs of Nervous System Products List
Figure Global and Europe L-Dopa Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Carbidopa Drugs of Nervous System Products List
Figure Global and Europe Carbidopa Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Benserazide Drugs of Nervous System Products List
Figure Global and Europe Benserazide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Sinemet Drugs of Nervous System Products List
Figure Global and Europe Sinemet Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Selegiline Drugs of Nervous System Products List
Figure Global and Europe Selegiline Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Amantadine Drugs of Nervous System Products List
Figure Global Amantadine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Bromocriptine Drugs of Nervous System Products List
Figure Global Bromocriptine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Pergolide Drugs of Nervous System Products List
Figure Global Pergolide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Artane Drugs of Nervous System Products List
Figure Global Artane Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global and Europe Drugs of Nervous System Sales (MT) by Product Antimyasthenics (2012-2022)
Table Global and Europe Drugs of Nervous System Sales Market Share by Product Antimyasthenics (2012-2022)
Figure Global and Europe Drugs of Nervous System Sales Market Share by Product Antimyasthenics in 2016
Table Global and Europe Drugs of Nervous System Revenue (Million USD) by Product Antimyasthenics (2012-2022)
Table Global and Europe Drugs of Nervous System Revenue Market Share by Product Antimyasthenics (2012-2022)
Figure Global and Europe Drugs of Nervous System Revenue Market Share by Product Antimyasthenics in 2016
Table Global and Europe Drugs of Nervous System Price (USD/T) by Product Antimyasthenics (2012-2022)
Table Top Brands of Neostigmine Drugs of Nervous System Products List
Figure Global and Europe Neostigmine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Neostigmine Methylsulfate Drugs of Nervous System Products List
Figure Global and Europe Neostigmine Methylsulfate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Pyridostigmine Bromide Drugs of Nervous System Products List
Figure Global and Europe Pyridostigmine Bromide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Galanthamine Drugs of Nervous System Products List
Figure Global and Europe Galanthamine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Edrophonium Chloride Drugs of Nervous System Products List
Figure Global and Europe Edrophonium Chloride Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global and Europe Drugs of Nervous System Sales (MT) by Product Antiepileptics (2012-2022)
Table Global and Europe Drugs of Nervous System Sales Market Share by Product Antiepileptics (2012-2022)
Figure Global and Europe Drugs of Nervous System Sales Market Share by Product Antiepileptics in 2016
Table Global and Europe Drugs of Nervous System Revenue (Million USD) by Product Antiepileptics (2012-2022)
Table Global and Europe Drugs of Nervous System Revenue Market Share by Product Antiepileptics (2012-2022)
Figure Global and Europe Drugs of Nervous System Revenue Market Share by Product Antiepileptics in 2016
Table Global and Europe Drugs of Nervous System Price (USD/T) by Product Antiepileptics (2012-2022)
Table Top Brands of Phenytoin Sodium Drugs of Nervous System Products List
Figure Global and Europe Phenytoin Sodium Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Carbamazepine Drugs of Nervous System Products List
Figure Global and Europe Carbamazepine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Phenobarbital Drugs of Nervous System Products List
Figure Global and Europe Phenobarbital Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Primidone Drugs of Nervous System Products List
Figure Global and Europe Primidone Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Ethosuximide Drugs of Nervous System Products List
Figure Global and Europe Ethosuximide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Sodium valproate Drugs of Nervous System Products List
Figure Global Sodium valproate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Clonazepam Drugs of Nervous System Products List
Figure Global Clonazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Trimethadione Drugs of Nervous System Products List
Figure Global Trimethadione Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Lamotrigine Drugs of Nervous System Products List
Figure Global Lamotrigine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Sultiame Drugs of Nervous System Products List
Figure Global Sultiame Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Felbamate Drugs of Nervous System Products List
Figure Global Felbamate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Levetiracetam Drugs of Nervous System Products List
Figure Global Levetiracetam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Topamax Drugs of Nervous System Products List
Figure Global Topamax Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global and Europe Drugs of Nervous System Sales (MT) by Product Cerebrovascular disease drugs (2012-2022)
Table Global and Europe Drugs of Nervous System Sales Market Share by Product Cerebrovascular disease drugs (2012-2022)
Figure Global and Europe Drugs of Nervous System Sales Market Share by Product Cerebrovascular disease drugs in 2016
Table Global and Europe Drugs of Nervous System Revenue (Million USD) by Product Cerebrovascular disease drugs (2012-2022)
Table Global and Europe Drugs of Nervous System Revenue Market Share by Product Cerebrovascular disease drugs (2012-2022)
Figure Global and Europe Drugs of Nervous System Revenue Market Share by Product Cerebrovascular disease drugs in 2016
Table Global and Europe Drugs of Nervous System Price (USD/T) by Product Cerebrovascular disease drugs (2012-2022)
Table Top Brands of Nimodipine Drugs of Nervous System Products List
Figure Global and Europe Nimodipine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Carfergot Drugs of Nervous System Products List
Figure Global and Europe Carfergot Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Mannitol Drugs of Nervous System Products List
Figure Global and Europe Mannitol Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Acetazolamide Drugs of Nervous System Products List
Figure Global and Europe Acetazolamide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Piracetam Drugs of Nervous System Products List
Figure Global and Europe Piracetam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global and Europe Drugs of Nervous System Sales (MT) by Product Sedative-hypnotic drugs (2012-2022)
Table Global and Europe Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs (2012-2022)
Figure Global and Europe Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs in 2016
Table Global and Europe Drugs of Nervous System Revenue (Million USD) by Product Sedative-hypnotic drugs (2012-2022)
Table Global and Europe Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs (2012-2022)
Figure Global and Europe Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs in 2016
Table Global and Europe Drugs of Nervous System Price (USD/T) by Product Sedative-hypnotic drugs (2012-2022)
Table Top Brands of Diazepam Drugs of Nervous System Products List
Figure Global and Europe Diazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Chlordiazepoxide Drugs of Nervous System Products List
Figure Global and Europe Chlordiazepoxide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Oxazepam Drugs of Nervous System Products List
Figure Global and Europe Oxazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Nitrazepam Drugs of Nervous System Products List
Figure Global and Europe Nitrazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Flunitrazepam Drugs of Nervous System Products List
Figure Global and Europe Flunitrazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Estazolam Drugs of Nervous System Products List
Figure Global Estazolam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Lorazepam Drugs of Nervous System Products List
Figure Global Lorazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Meprobamate Drugs of Nervous System Products List
Figure Global Meprobamate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Hydroxyzine Drugs of Nervous System Products List
Figure Global Hydroxyzine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Captodiamine Drugs of Nervous System Products List
Figure Global Captodiamine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Piperilate Drugs of Nervous System Products List
Figure Global Piperilate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Chlormezanone Drugs of Nervous System Products List
Figure Global Chlormezanone Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Trimetozine Drugs of Nervous System Products List
Figure Global Trimetozine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Captodiamine Drugs of Nervous System Products List
Figure Global Oryzanol Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Benzoctamine Drugs of Nervous System Products List
Figure Global Benzoctamine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Gastrodine Drugs of Nervous System Products List
Figure Global Gastrodine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Glutethimide Drugs of Nervous System Products List
Figure Global Glutethimide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Global Drugs of Nervous System Sales (MT) by Product Sedative-hypnotic drugs (2012-2022)
Table Global Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs (2012-2022)
Figure Global Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs in 2016
Table Global Drugs of Nervous System Revenue (Million USD) by Product Sedative-hypnotic drugs (2012-2022)
Table Global Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs (2012-2022)
Figure Global Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs in 2016
Table Global Drugs of Nervous System Price (USD/T) by Product Sedative-hypnotic drugs (2012-2022)
Table Top Brands of Diazepam Drugs of Nervous System Products List
Figure Global Diazepam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Citicoline Drugs of Nervous System Products List
Figure Global Citicoline Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Nikethamide Drugs of Nervous System Products List
Figure Global Nikethamide Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Lobeline Drugs of Nervous System Products List
Figure Global Lobeline Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Piracetam Drugs of Nervous System Products List
Figure Global Piracetam Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Ligustrazine Drugs of Nervous System Products List
Figure Global Ligustrazine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Flunarizine Drugs of Nervous System Products List
Figure Global Flunarizine Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Cerebroprotein Hydrolysate Drugs of Nervous System Products List
Figure Global Cerebroprotein Hydrolysate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Sodium Aescinate Drugs of Nervous System Products List
Figure Global Sodium Aescinate Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Top Brands of Troxerutin Drugs of Nervous System Products List
Figure Global Troxerutin Drugs of Nervous System Sales (MT) and Growth Rate (2012-2022)
Table Zhejiang Chiral Medicine Chemicals Company Details and Competitors
Table Zhejiang Chiral Medicine Chemicals Key Drugs of Nervous System Models and Performance
Table Zhejiang Chiral Medicine Chemicals Drugs of Nervous System Business SWOT Analysis and Forecast
Table Zhejiang Chiral Medicine Chemicals Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Zhejiang Chiral Medicine Chemicals Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure Zhejiang Chiral Medicine Chemicals Drugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Zhejiang Chiral Medicine Chemicals Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Figure Zhejiang Chiral Medicine Chemicals Drugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table S.P. QUIMICA, S.A. ES 43330 Riudoms Company Details and Competitors
Table S.P. QUIMICA, S.A. ES 43330 Riudoms Key Drugs of Nervous System Models and Performance
Table S.P. QUIMICA, S.A. ES 43330 Riudoms Drugs of Nervous System Business SWOT Analysis and Forecast
Table S.P. QUIMICA, S.A. ES 43330 Riudoms Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure S.P. QUIMICA, S.A. ES 43330 Riudoms Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure S.P. QUIMICA, S.A. ES 43330 Riudoms Drugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure S.P. QUIMICA, S.A. ES 43330 Riudoms Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Figure S.P. QUIMICA, S.A. ES 43330 Riudoms Drugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Moehs Iberica S.L. ES 08191 Rubi Company Details and Competitors
Table Moehs Iberica S.L. ES 08191 Rubi Key Drugs of Nervous System Models and Performance
Table Moehs Iberica S.L. ES 08191 Rubi Drugs of Nervous System Business SWOT Analysis and Forecast
Table Moehs Iberica S.L. ES 08191 Rubi Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Moehs Iberica S.L. ES 08191 Rubi Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure Moehs Iberica S.L. ES 08191 Rubi Drugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Moehs Iberica S.L. ES 08191 Rubi Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Figure Moehs Iberica S.L. ES 08191 Rubi Drugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table TEVA CZECH INDUSTRIES Opava-Komarov Company Details and Competitors
Table TEVA CZECH INDUSTRIES Opava-Komarov Key Drugs of Nervous System Models and Performance
Table TEVA CZECH INDUSTRIES Opava-Komarov Drugs of Nervous System Business SWOT Analysis and Forecast
Table TEVA CZECH INDUSTRIES Opava-Komarov Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure TEVA CZECH INDUSTRIES Opava-Komarov Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure TEVA CZECH INDUSTRIES Opava-Komarov Drugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure TEVA CZECH INDUSTRIES Opava-Komarov Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Figure TEVA CZECH INDUSTRIES Opava-Komarov Drugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table PATHEON AUSTRIA GMBH & CO. KG AT Linz Company Details and Competitors
Table PATHEON AUSTRIA GMBH & CO. KG AT Linz Key Drugs of Nervous System Models and Performance
Table PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Business SWOT Analysis and Forecast
Table PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure PATHEON AUSTRIA GMBH & CO. KG AT Linz Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Table ALKALOIDA CHEMICAL Tiszavasvari Company Details and Competitors
Table ALKALOIDA CHEMICAL Tiszavasvari Key Drugs of Nervous System Models and Performance
Table ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Business SWOT Analysis and Forecast
Table ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Sales(Million Unit) and Growth Rate (%) (2012-2022)
Figure ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Sales Revenue(Million USD) and Growth Rate (%) (2012-2022)
Figure ALKALOIDA CHEMICAL Tiszavasvari Drugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Siegfried Ltd CH 4800 ZofingenCompany Details and Competitors
Table Siegfried Ltd CH 4800 ZofingenKey Drugs of Nervous System Models and Performance
Table Siegfried Ltd CH 4800 ZofingenDrugs of Nervous System Business SWOT Analysis and Forecast
Table Siegfried Ltd CH 4800 ZofingenDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Siegfried Ltd CH 4800 ZofingenDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Siegfried Ltd CH 4800 ZofingenDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Figure Siegfried Ltd CH 4800 ZofingenDrugs of Nervous System Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Table KATWIJK CHEMIE BV NL BA Katwijk ZH Company Details and Competitors
Table KATWIJK CHEMIE BV NL BA Katwijk ZH Key Drugs of Nervous System Models and Performance
Table KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Business SWOT Analysis and Forecast
Table KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure KATWIJK CHEMIE BV NL BA Katwijk ZH Drugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Company Details and Competitors
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Key Drugs of Nervous System Models and Performance
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Business SWOT Analysis and Forecast
Table F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure F.I.S. Fabbrica Italiana Sintetici S.p.A. IT 36075 Montecchio Maggiore Drugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Ergypharm FR 67452 Mundolsheim Company Details and Competitors
Table Ergypharm FR 67452 Mundolsheim Key Drugs of Nervous System Models and Performance
Table Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Business SWOT Analysis and Forecast
Table Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Ergypharm FR 67452 Mundolsheim Drugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table HARMAN FINOCHEM LIMITED IN MumbaiCompany Details and Competitors
Table HARMAN FINOCHEM LIMITED IN MumbaiKey Drugs of Nervous System Models and Performance
Table HARMAN FINOCHEM LIMITED IN MumbaiDrugs of Nervous System Business SWOT Analysis and Forecast
Table HARMAN FINOCHEM LIMITED IN MumbaiDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure HARMAN FINOCHEM LIMITED IN MumbaiDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure HARMAN FINOCHEM LIMITED IN MumbaiDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure HARMAN FINOCHEM LIMITED IN MumbaiDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table MSD PHARMA (SINGAPORE) PTE. LTD.ItalyCompany Details and Competitors
Table MSD PHARMA (SINGAPORE) PTE. LTD.ItalyKey Drugs of Nervous System Models and Performance
Table MSD PHARMA (SINGAPORE) PTE. LTD.ItalyDrugs of Nervous System Business SWOT Analysis and Forecast
Figure MSD PHARMA (SINGAPORE) PTE. LTD.ItalyDrugs of Nervous System Product Picture
Table MSD PHARMA (SINGAPORE) PTE. LTD.ItalyDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure MSD PHARMA (SINGAPORE) PTE. LTD.ItalyDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure MSD PHARMA (SINGAPORE) PTE. LTD.ItalyDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure MSD PHARMA (SINGAPORE) PTE. LTD.ItalyDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Orion Corporation FinlandCompany Details and Competitors
Table Orion Corporation FinlandKey Drugs of Nervous System Models and Performance
Table Orion Corporation FinlandDrugs of Nervous System Business SWOT Analysis and Forecast
Table Orion Corporation FinlandDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Orion Corporation FinlandDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Orion Corporation FinlandDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Orion Corporation FinlandDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Gedeon Richter Plc. HungaryCompany Details and Competitors
Table Gedeon Richter Plc. HungaryKey Drugs of Nervous System Models and Performance
Table Gedeon Richter Plc. HungaryDrugs of Nervous System Business SWOT Analysis and Forecast
Figure Gedeon Richter Plc. HungaryDrugs of Nervous System Product Picture
Table Gedeon Richter Plc. HungaryDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Gedeon Richter Plc. HungaryDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Gedeon Richter Plc. HungaryDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Gedeon Richter Plc. HungaryDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Novartis Farma S.P.A. ItalyCompany Details and Competitors
Table Novartis Farma S.P.A. ItalyKey Drugs of Nervous System Models and Performance
Table Novartis Farma S.P.A. ItalyDrugs of Nervous System Business SWOT Analysis and Forecast
Figure Novartis Farma S.P.A. ItalyDrugs of Nervous System Product Picture
Table Novartis Farma S.P.A. ItalyDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Novartis Farma S.P.A. ItalyDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Novartis Farma S.P.A. ItalyDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Novartis Farma S.P.A. ItalyDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Gedeon Richter Plc.HungaryCompany Details and Competitors
Table Gedeon Richter Plc.HungaryKey Drugs of Nervous System Models and Performance
Table Gedeon Richter Plc.HungaryDrugs of Nervous System Business SWOT Analysis and Forecast
Figure Gedeon Richter Plc.HungaryDrugs of Nervous System Product Picture
Table Gedeon Richter Plc.HungaryDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Gedeon Richter Plc.HungaryDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Gedeon Richter Plc.HungaryDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Gedeon Richter Plc.HungaryDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Janssen Pharmaceutica N.V. BelgiumCompany Details and Competitors
Table Janssen Pharmaceutica N.V. BelgiumKey Drugs of Nervous System Models and Performance
Table Janssen Pharmaceutica N.V. BelgiumDrugs of Nervous System Business SWOT Analysis and Forecast
Figure Janssen Pharmaceutica N.V. BelgiumDrugs of Nervous System Product Picture
Table Janssen Pharmaceutica N.V. BelgiumDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Janssen Pharmaceutica N.V. BelgiumDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Janssen Pharmaceutica N.V. BelgiumDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Janssen Pharmaceutica N.V. BelgiumDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Sanofi Aventis Deutschland FranceCompany Details and Competitors
Table Sanofi Aventis Deutschland FranceKey Drugs of Nervous System Models and Performance
Table Sanofi Aventis Deutschland FranceDrugs of Nervous System Business SWOT Analysis and Forecast
Figure Sanofi Aventis Deutschland FranceDrugs of Nervous System Product Picture
Table Sanofi Aventis Deutschland FranceDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Sanofi Aventis Deutschland FranceDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Sanofi Aventis Deutschland FranceDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Sanofi Aventis Deutschland FranceDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Taiwan Biotech Co.Ltd Company Details and Competitors
Table Taiwan Biotech Co.Ltd Key Drugs of Nervous System Models and Performance
Table Taiwan Biotech Co.Ltd Drugs of Nervous System Business SWOT Analysis and Forecast
Figure Taiwan Biotech Co.Ltd Drugs of Nervous System Product Picture
Table Taiwan Biotech Co.Ltd Drugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Taiwan Biotech Co.Ltd Drugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Taiwan Biotech Co.Ltd Drugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Taiwan Biotech Co.Ltd Drugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table GlaxoSmithKline Pharmaceuticals S.A.PolandCompany Details and Competitors
Table GlaxoSmithKline Pharmaceuticals S.A.PolandKey Drugs of Nervous System Models and Performance
Table GlaxoSmithKline Pharmaceuticals S.A.PolandDrugs of Nervous System Business SWOT Analysis and Forecast
Figure GlaxoSmithKline Pharmaceuticals S.A.PolandDrugs of Nervous System Product Picture
Table GlaxoSmithKline Pharmaceuticals S.A.PolandDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure GlaxoSmithKline Pharmaceuticals S.A.PolandDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure GlaxoSmithKline Pharmaceuticals S.A.PolandDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure GlaxoSmithKline Pharmaceuticals S.A.PolandDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table Actavis hf. IcelandCompany Details and Competitors
Table Actavis hf. IcelandKey Drugs of Nervous System Models and Performance
Table Actavis hf. IcelandDrugs of Nervous System Business SWOT Analysis and Forecast
Figure Actavis hf. IcelandDrugs of Nervous System Product Picture
Table Actavis hf. IcelandDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure Actavis hf. IcelandDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure Actavis hf. IcelandDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure Actavis hf. IcelandDrugs of Nervous System Revenue Market Share (%) in Global and Europe (2012-2022)
Table UCB Pharma S.A.BelgiumCompany Details and Competitors
Table UCB Pharma S.A.BelgiumKey Drugs of Nervous System Models and Performance
Table UCB Pharma S.A.BelgiumDrugs of Nervous System Business SWOT Analysis and Forecast
Figure UCB Pharma S.A.BelgiumDrugs of Nervous System Product Picture
Table UCB Pharma S.A.BelgiumDrugs of Nervous System Output (MT), Revenue (Million USD), Price (USD/T) and Gross Margin (%) (2012-2022)
Figure UCB Pharma S.A.BelgiumDrugs of Nervous System Sales Growth Rate (%) (2012-2022)
Figure UCB Pharma S.A.BelgiumDrugs of Nervous System Sales Market Share (%) in Global and Europe (2012-2022)
Figure UCB Pharma S.A.BelgiumDrugs of Nervous System

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *